Table 6.
Commercial and DNA rabies vaccines.
Vaccine | Vector | Dosage | Price | Vaccination ages |
Protection | Ref. |
---|---|---|---|---|---|---|
Rabvac™ (Fort Dodge, KS, USA) |
Killed virus with adjuvant |
One 1-ml dose sc. or im. Revaccinate 1 year later and every 3 years thereafter |
US$74.99/50 doses ($1.50/ dose) |
3 months | Dogs, cats and horses Neutralizing antibodies in dogs within 2 months, 100% against lethal challenge |
[20] |
Defensor 3® (Pfizer, NY, USA) |
Chemically inactivated rabies virus with adjuvant |
One 1-ml dose sc. Revaccinate 1 year later and every 3 years thereafter |
US$21.95/ten doses (US$2.20/ dose) |
3 months | Dogs, cats, sheep and cattle, but extends to raccoons and bats |
|
Prorab® (Intervet, The Netherlands) |
Killed virus with adjuvant |
One 1-ml dose sc. or im. with annual revaccination |
US$13.85/ten doses (US$1.39/ dose) |
3 months | Dogs, cats and sheep | |
Imrab® (Merial Animal Health Ltd, UK) |
Inactivated rabies virus |
One 1-ml dose sc. or im. Revaccinate 2 year later and every 3 years thereafter |
US$102.97/50 doses (US$2.06/dose) |
3 months | Cats, dogs, sheep, cattle, horses and ferrets Virus-neutralizing antibodies |
|
Raboral V-RG® (Merial Animal Health Ltd) |
Nonpathogenic virus with small portion of viral RNA encoding G protein of the rabies virus |
2 ml of vaccine in fish meal or dog food bait |
US$1.30/ vaccine-bait unit |
For adult wild animals |
Protects coyotes and raccoons within 14 days |
|
DNA vaccine (Tesoro-Cruz et al. 2008) |
Plasmid encoding glycoprotein of rabies virus |
100 µg of DNA im., intranasally and intradermally with booster 30 days later |
Unknown | 1–2 years | Neutralizing antibodies in cats within 15 days and in mice via passive transfer of cat sera/ antibodies. 100% protection in mice. Protection from lethal challenge for cats (100% for intradermal vaccination and 67% for im. route) |
[91] |
DNA vaccine (Lodmell et al. 2006) |
Plasmid encoding glycoprotein of rabies virus |
100-µg DNA intradermally in ear Pinnae |
Unknown | 12–14 months | Neutralizing antibodies within 2 months in dogs, persisting for 6 months. 100% protection against lethal challenge |
[20] |
im.: Intramuscular; sc.: Subcutaneous.